The Effect of Dihydroartemisinin in PCOS
NCT05465135
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:
Dihydroartemisinin
Sponsor
Shanghai Zhongshan Hospital